Abstract
Background Cardiovascular diseases (CVD) are the leading cause of mortality in China. Depression and sleep disturbances are recognized as risk factors for CVD, but their interplay and combined effects remain unclear. This study examines how sleep duration and depression interact to influence CVD risk.
Methods We analyzed data from five waves of the China Health and Retirement Longitudinal Study (CHARLS) between 2011 and 2020. The final sample included 12,050 individuals aged 45 and above. Sleep duration was categorized as 6 hours or less, 6–8 hours and >8 hours. Depression was assessed using the CESD-10 score and categorized as no depression, mild/moderate depression, and severe depression. Cox proportional hazards models assessed the association between sleep, depression, and CVD. Mediation analysis explored depression’s role in this relationship.
Results Short sleep duration was associated with a higher CVD risk (HR 1.19; 95% CI: 1.03– 1.38). Restricted cubic spline (RCS) analysis showed a U-shaped association between sleep duration and CVD risk, with the lowest risk observed at 7.61 hours of sleep. Severe depression further increased CVD risk when combined with short sleep duration (HR 2.08; 95% CI: 1.46-2.95) or long sleep duration (HR 2.08; 95% CI: 1.05-5.35). Mediation analysis revealed that depression explained 43.8% of the total effect of short sleep on CVD.
Conclusions Both short sleep and depression independently raise the risk of CVD, with depression partially mediating the effect of sleep on cardiovascular health. Interventions targeting both sleep and mental health could reduce CVD risk in high-risk populations.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by the National Science Foundation of China (No: 81800292).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study was approved by the Biomedical Ethics Review Committee of Peking University (IRB00001052-11015), and informed consent was obtained from all subjects
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Availability of data and materials
The data that support the fndings of this study are available from the website of the China Health and Retirement Longitudinal Study (CHARLS) at http://charls.pku.edu.cn/.
